Journal of Psychosomatic Research
Volume 67, Issue 6 , Pages 585-590 , December 2009

Neurosurgical treatment for Gilles de la Tourette syndrome: The Italian perspective

  • Mauro Porta

      Affiliations

    • Movement Disorders and Tourette Centre, IRCCS Galeazzi, Milan, Italy
    • ,
  • Marco Sassi

      Affiliations

    • Department of Functional Neurosurgery, IRCCS Galeazzi, Milan, Italy
    • ,
  • Fizzah Ali

      Affiliations

    • Department of Neuropsychiatry, University of Birmingham and BSMHFT, Birmingham, United Kingdom
    • ,
  • Andrea Eugenio Cavanna

      Affiliations

    • Department of Neuropsychiatry, University of Birmingham and BSMHFT, Birmingham, United Kingdom
    • Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, London, United Kingdom
    • Corresponding Author InformationCorresponding author. Department of Neuropsychiatry, Birmingham and Solihull Mental Health NHS Foundation Trust, Barberry Building, B152FG Birmingham, United Kingdom.
    • ,
  • Domenico Servello

      Affiliations

    • Functional Neurosurgical Unit, IRCCS Galeazzi, Milan, Italy

Received 13 March 2009 ,Revised 4 June 2009 ,Accepted 10 June 2009.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text revised. Washington, DC: APA; 2000;(DSM-IV-TR)
  2. World Health Organisation . International statistical classification of diseases and related health problems: ICD-10, 10th revision. Geneva: World Health Organization; 1992;
  3. Leckman JF. Tourette's syndrome. Lancet. 2002;360:1577–1586
  4. Robertson MM. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J Psychosom Res. 2008;65:461–472
  5. Robertson MM. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 2: tentative explanations for differing prevalence figures in GTS, including the possible effects of psychopathology, aetiology, cultural differences, and differing phenotypes. J Psychosom Res. 2008;65:473–486
  6. Cavanna AE, Servo S, Monaco F, Robertson MM. More than tics: the behavioral spectrum of Gilles de la Tourette syndrome. J Neuropsy Clin Neurosci. 2008;21:13–23
  7. Freeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P. An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol. 2000;42:436–447
  8. Robertson MM. Invited review. Tourette Syndrome, associated conditions and the complexities of treatment. Brain. 2000;123:425–462
  9. Leckman JF, Bloch MH, Scahill L, King RA. Tourette syndrome: the self under siege. J Child Neurol. 2006;21:642–649
  10. Ackermans L, Temel Y, Cath D, van der Linden C, Bruggeman R, Kleijer M, et al. for the Dutch Flemish Tourette Surgery Study Group Deep Brain Stimulation in Tourette's Syndrome: two targets?. Mov Disord. 2006;21:709–713
  11. Cavanna AE, Schrag A, Morley D, Orth M, Robertson MM, Joyce E, et al. The Gilles de la Tourette syndrome-Quality of Life scale (GTS-QOL): development and validation. Neurology. 2008;71:1410–1416
  12. Elstner K, Selai CE, Trimble MR, Robertson MM. Quality of life (QOL) of patients with Gilles de la Tourette's Syndrome. Acta Psych Scand. 2001;103:52–59
  13. Erenberg G, Cruse RP, Rothner DA. The natural history of Tourette's syndrome: a follow-up study. Ann Neurol. 1987;22:383–385
  14. Cooper C, Robertson MM, Livingston G. Psychological morbidity and caregiver burden in parents of children with Gilles de la Tourette Syndrome compared with parents of children with asthma. J Am Acad Child Adolesc Psychiatry. 2003;42:1370–1375
  15. Leckman JF, Zhang H, Vitale A, Lahnin F, Lynch K, Bondi C, et al. Course of tic severity in Tourette's syndrome: the first two decades. Paediatrics. 1998;102:14–19
  16. Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ. Clonidine treatment of Tourette's Syndrome. Arch Gen Psychiatry. 1991;48:324–328
  17. Scahill LD, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E, et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and ADHD. Am J Psychiatry. 2001;158:1067–1074
  18. Tourette Syndrome Study Group. Treatment of ADHD in children with tics: a randomised controlled trial. Neurology. 2002;58:527–536
  19. Kawohl W, Schneider F, Vernaleken I, Neuner I. Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients. World J Biol Psychiatry. 2008;11:1–5
  20. Kawohl W, Schneider F, Vernaleken I, Neuner I. Chronic motor tic disorder and aripiprazole: first experience in adult patients. J Neuropsychiatry Clin Neurosci [in press].
  21. Carr JE, Chong IM. Habit reversal treatment of tic disorders: a methodological critique of the literature. Behav Modif. 2005;29:858–875
  22. Marsh R, Zhu H, Wang Z, Skudlarski P, Peterson BS. A developmental fMRI study of self-regulatory control in Tourette syndrome. Am J Psychiatry. 2007;164:955–966
  23. Neuner I, Podoll K, Janouschek H, Michel TM, Sheldrick AJ, Schneider F. From psychosurgery to neuromodulation: deep brain stimulation for intractable Tourette syndrome. World J Biol Psychiatry. 2008;13:1–11
  24. Temel Y, Visser-Vandewalle V. Surgery in Tourette syndrome. Mov Disord. 2004;19:3–14
  25. Temel Y, van Lankveld JJ, Boon P, Spincemaille GH, van der Linden C, Visser-Vandewalle V. Deep brain stimulation of the thalamus can influence penile erection. Int J Impot Res. 2004;16:91–94
  26. Babel TB, Warnke PC, Ostertag CB. Immediate and long term outcome after infrathalamic and thalamic lesioning for intractable Tourette syndrome. J Neurol Neurosurg Psychiatry. 2001;70:666–671
  27. Bajwa RJ, de Lotbiniere AJ, King RA, Jabbari B, Quatrano S, Kunze K, et al. Deep brain stimulation in Tourette syndrome. Mov Disord. 2007;22:1346–1350
  28. Dehning S, Mehrkens J-H, Muller N, Botzel K. Therapy-refractory Tourette syndrome: beneficial outcome with globus pallidus internus deep brain stimulation. Mov Disord. 2008;23:1300–1302
  29. Kuhn J, Lenartz D, Mai JK, Huff W, Lee SH, Koulousakis A, et al. Deep brain stimulation of the nucleus accumbens and the internal capsule in therapeutically refractory Tourette syndrome. J Neurol. 2007;254:963–965
  30. Vandewalle V, van der Linden C, Groenewegen HJ, Caemaert J. Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet. 1999;353:724
  31. Shields DC, Cheng ML, Flaherty AW, Gale JT, Eskandar EN. Microelectrode-guided deep brain stimulation for Tourette syndrome: within-subject comparison of different stimulation sites. Stereotact Funct Neurosurg. 2008;86:87–91
  32. Welter ML, Mallet L, Houeto JL, Karachi C, Czernecki V, Cornu P, et al. Internal pallidal and thalamic stimulation in patients with Tourette syndrome. Arch Neurol. 2008;65:952–957
  33. Flaherty AW, Williams ZM, Amirnovin R, Kasper E, Rauch SL, Cosgrove GR, et al. Deep brain stimulation of the anterior internal capsule for the treatment of Tourette syndrome: technical case report. Neurosurgery. 2005;57:403
  34. Visser-Vandewalle V, Temel Y, Boon P, Vreeling F, Colle H, Hoogland G, et al. Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome. Report of three cases. J Neurosurg. 2003;99:1094–1100
  35. Diederich NJ, Kalteis K, Stamenkovic M, Pieri V, Alesch F. Efficient internal pallidal stimulation in Gilles de la Tourette syndrome: a case report. Mov Disord. 2005;20:1496–1499
  36. Jl Houeto, Karachi C, Mallet L, Pillon B, Yelnik J, Mesnage V, et al. Tourette's syndrome and deep brain stimulation. J Neurol Neurosurg Psychiatry. 2005;76:992–995
  37. Shahed J, Poysky J, Kenney C, Simpson R, Jankovic J. GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric comorbidities. Neurology. 2007;68:159–160
  38. Maciunas RJ, Maddux BN, Riley DE, Whitney CM, Schoenberg MR, Ogrocki PJ, et al. Prospective randomized double-blind trial of bilateral thalamic deep brain stimulation in adults with Tourette syndrome. J Neurosurg. 2007;107:1004–1014
  39. Servello D, Porta M, Sassi M, Brambilla A, Robertson MM. Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry. 2008;79:136–142
  40. Neuner I, Podoll K, Lenartz D, Sturm V, Shneider F. Deep Brain Stimulation in the Nucleus Accumbens for Intractable Tourette's Syndrome: follow-up report of 36 months. Biol Psychiatry. 2009;65:5–6
  41. van der Linden C, Colle H, Vandewalle V, Alessi G, Rijckaert D, De Waele L. Successful treatment of tics with bilateral internal pallidum stimulation in a 27-year-old male patient with Gilles de la Tourette syndrome. Mov Disord. 2002;17:341
  42. Fodstad H, Hariz M. Electricity in the treatment of nervous system disease. Arch Neurochir Suppl. 2007;97:11–19
  43. Coffey RJ. Deep Brain Stimulation Devices: a brief technical history and review. Artificial Organs. 2008;33:208–220
  44. Nuttin BJ, Gabriëls LA, Cosyns PR, Meyerson BA, Andréewitch S, Sunaert SG, et al. Long-term Electrical Capsular Stimulation in Patients with Obsessive-Compulsive Disorder. Neurosurgery. 2003;52:1263–1274
  45. Greenberg BD, Gabriels LA, Malone DA, Rezai AR, Friehs GM, Okun MS, et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry [in press].
  46. Malone DA, Dougherty DD, Rezai AR, Carpenter LL, Friehs GM, Eskandar EN, et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry. 2009;65:267–275
  47. Appleby BS, Duggan PS, Regenberg A, Rabins PV. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years' experience. Mov Disord. 2007;22:1722–1728
  48. Castelli L, Zibetti M, Rizzi L, Caglio M, Lanotte M, Lopiano L. Neuropsychiatric symptoms three years after subthalamic DBS in PD patients: a case-control study. J Neurol. 2008;255:1515–1520
  49. Zahodne LB, Okun MS, Foote KD, Fernandez HH, Rodriguez RL, Kirsch-Darrow L, et al. Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinson's disease: a controlled study using reliable change. Clin Neuropsychol. 2009;23:385–405
  50. McNeely HE, Mayberg HS, Lozano AM, Kennedy SH. Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: preliminary results over 12 months. J Nerv Ment Dis. 2008;196:405–410
  51. Mink JW, Walkup J, Frey KA, Como P, Cath D, Delong MR, et al. Tourette Syndrome Association, Inc. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord. 2006;21:1831–1838
  52. Braun AR, Randolph C, Stoetter B, Mohr E, Cox C, Vladar K, et al. The functional anatomy of Tourette's syndrome: an FDG-PET study. II. Relationships between regional cerebral metabolism and associated behavioural and cognitive features of the illness. Neuropsychopharmacology. 1995;13:151–168
  53. Piasecki SD, Jefferson JW. Psychiatric complications of deep brain stimulation for Parkinson's disease. J Clin Psychiatry. 2004;65:845–849
  54. Hariz MI. Complications of Deep Brain Surgery. Mov Disord. 2002;17:162–166
  55. Visser-Vandewalle V, Ackermans L, van der Linden C, Temel Y, Tijssen MA, Schruers KR, et al. Deep brain stimulation in Gilles de la Tourette's syndrome. Neurosurgery. 2006;58:590
  56. Umemura A, Jaggi JL, Hurtig HI, Siderowf AD, Colcher A, Stern MB, et al. Deep brain stimulation for movement Disorders: morbidity and mortality in 109 patients. J Neurosurg. 2003;98:779–784
  57. Lyons KE, Wilkinson SB, Overman J, Pahwa R. Surgical and hardware related Complications of subthalamic stimulation: a series of 160 procedures. Neurology. 2004;63:612–616

PII: S0022-3999(09)00228-1

doi: 10.1016/j.jpsychores.2009.06.001

Journal of Psychosomatic Research
Volume 67, Issue 6 , Pages 585-590 , December 2009

Article Tools